Senior insider sale
SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$248.2K
2.49K shares
What this filing means
NICAISE CLAUDE plans to sell 2.49K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $248.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/12/2025ACC: 0001972362-25-000284
2.49K
Shares to sell
$248.2K
Approx. market value
2.49K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
3/12/2025
2.49KTotal acquired2.49K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2025 | STOCK OPTION EXERCISE COMPENSATION | 2.49K | — |
| Total | 2.49K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.49K
Market value
$248.2K
3/12/2025
Total
Units
2.49K
Value
$248.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/12/2025 | 2.49K | $248.2K | NASDAQ | Planned |
| Total | 2.49K | $248.2K | ||